TrialCancer science2021

Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials.

Masakazu Toi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.